EDAP TMS CE-marks ultrasound prostate cancer treatment:
This article was originally published in Clinica
Executive Summary
EDAP TMS has CE-marked its high intensity focused ultrasound technology for treating localised prostate cancer. Incorporated in the company's Ablatherm device, the minimally invasive technology uses a focused ultrasound beam to destroy tumours without damaging surrounding tissue.